These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27246751)

  • 21. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
    Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
    Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical timolol for small infantile hemangioma: a new therapy option.
    Weissenstein A; Straeter A; Villalon G; Bittmann S
    Turk J Pediatr; 2012; 54(2):156-8. PubMed ID: 22734302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
    Tawfik AA; Alsharnoubi J
    Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
    Babiak-Choroszczak L; Giżewska-Kacprzak K; Dawid G; Gawrych E; Bagłaj M
    Adv Clin Exp Med; 2019 Mar; 28(3):375-384. PubMed ID: 30659785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis.
    Zheng L; Li Y
    Arch Dermatol Res; 2018 May; 310(4):261-269. PubMed ID: 29362868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions for infantile haemangiomas of the skin: abridged Cochrane systematic review and GRADE assessments.
    Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
    Br J Dermatol; 2019 Mar; 180(3):527-533. PubMed ID: 30414269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergic contact dermatitis caused by timolol eyedrop application for infantile haemangioma.
    Sacchelli L; Vincenzi C; La Placa M; Piraccini BM; Neri I
    Contact Dermatitis; 2019 Apr; 80(4):255-256. PubMed ID: 30485454
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
    Chang TC; Estes R
    J AAPOS; 2014 Feb; 18(1):80-2. PubMed ID: 24568991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chinese expert consensus on the use of topical timolol maleate treatment of infantile hemangiomas].
    Zheng JW; Wang XK; Jiang CH; Qin ZP; Fan XD; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK; Lei SR
    Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):744-747. PubMed ID: 28275803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review.
    Kardasevic M; Dinarevic SM
    Med Arch; 2021 Apr; 75(2):158-161. PubMed ID: 34219878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma.
    Merino-Bohórquez V; Casas M; Caracuel F; Cameán M; Fernández-Anguita MJ; Ramírez-Soto G; Lucero MJ
    Pharm Dev Technol; 2015; 20(5):562-9. PubMed ID: 25047057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
    He L; Huang G
    J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
    Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
    Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and treatment of infantile haemangioma in preterm infants.
    Goelz R; Poets CF
    Arch Dis Child Fetal Neonatal Ed; 2015 Jan; 100(1):F85-91. PubMed ID: 25352093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regimen for accelerated propranolol initial dosing (RAPID).
    Huang CY; Perman MJ; Yan AC
    Pediatr Dermatol; 2024; 41(4):621-627. PubMed ID: 38631683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment.
    Petrovic J; Trifunovic B; Vukomanovic G; Topalovic M; Trajkovic G; Parezanović V
    J Dermatolog Treat; 2017 Sep; 28(6):554-558. PubMed ID: 28043186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
    Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
    J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical Timolol for Infantile Haemangioma of the Orbit.
    Hildebrand GD; Sipkova Z
    Klin Monbl Augenheilkd; 2021 Oct; 238(10):1069-1076. PubMed ID: 34662921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser.
    Ying H; Zou Y; Yu W; Qiu Y; Ma G; Chang L; Gu Y; Lyu D; Lin X
    J Dermatol; 2017 Jun; 44(6):660-665. PubMed ID: 28191657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.